Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
Clinical trial NCT06757153 · RECRUITING
Trial details
- NCT number
- NCT06757153
- Sponsor
- Zhongnan Hospital
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-19
- Primary completion
- 2027-08-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.